Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Balck

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Neurological Research and Practice|June 21, 2021
Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19Max Borsche, Dirk Reichel, Anja Fellbrich, et al.
NPJ Parkinson'S Disease|July 14, 2023
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditionsTatiana Usnich, Björn Hauptmann, Henrike Hanssen, et al.
Science Advances|May 14, 2025
The role of dopaminergic medication and specific pathway alterations in idiopathic and <i>PRKN/PINK1</i>-mediated Parkinson's diseaseAlexander Balck, Max Borsche, Philip Campbell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 25, 2021
Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene ReviewAlexander Balck, Susen Schaake, Neele Sophie Kuhnke, et al.
BMC Public Health|July 7, 2022
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort studyAlexander Balck, Bandik Föh, Max Borsche, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 12, 2018
Utility and implications of exome sequencing in early-onset Parkinson's diseaseJoanne Trinh, Katja Lohmann, Hauke Baumann, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
How many do we miss? - Evaluation of age at onset and family history as selection criteria for genetic testing in Parkinson's diseaseAlexander Balck, Eva-Juliane Vollstedt, Ana Westenberger, et al.
Annals of Neurology|March 28, 2024
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification AssayAnnika Kluge, Max Borsche, Linn Streubel-Gallasch, et al.
Glia|December 7, 2013
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosisLars Tönges, Rene Günther, Martin Suhr, et al.
BMC Public Health|April 8, 2025
Spreading of SARS-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022: a mixed-cohort observational and repeated cross-sectional studyDaniel Alvarez-Fischer, Max Borsche, Alexander Balck, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Neurological Research and Practice|June 21, 2021
Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19Max Borsche, Dirk Reichel, Anja Fellbrich, et al.
NPJ Parkinson'S Disease|July 14, 2023
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditionsTatiana Usnich, Björn Hauptmann, Henrike Hanssen, et al.
Science Advances|May 14, 2025
The role of dopaminergic medication and specific pathway alterations in idiopathic and <i>PRKN/PINK1</i>-mediated Parkinson's diseaseAlexander Balck, Max Borsche, Philip Campbell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 25, 2021
Genotype-Phenotype Relations in Primary Familial Brain Calcification: Systematic MDSGene ReviewAlexander Balck, Susen Schaake, Neele Sophie Kuhnke, et al.
BMC Public Health|July 7, 2022
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study - a prospective population-based cohort studyAlexander Balck, Bandik Föh, Max Borsche, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 12, 2018
Utility and implications of exome sequencing in early-onset Parkinson's diseaseJoanne Trinh, Katja Lohmann, Hauke Baumann, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
How many do we miss? - Evaluation of age at onset and family history as selection criteria for genetic testing in Parkinson's diseaseAlexander Balck, Eva-Juliane Vollstedt, Ana Westenberger, et al.
Annals of Neurology|March 28, 2024
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification AssayAnnika Kluge, Max Borsche, Linn Streubel-Gallasch, et al.
Glia|December 7, 2013
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosisLars Tönges, Rene Günther, Martin Suhr, et al.
BMC Public Health|April 8, 2025
Spreading of SARS-CoV-2 among adult asylum seekers in refugee community shelters in Lübeck, Germany between 2020 and 2022: a mixed-cohort observational and repeated cross-sectional studyDaniel Alvarez-Fischer, Max Borsche, Alexander Balck, et al.
Pageof 3